NCT02608619View on ClinicalTrials.gov

Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Erdheim-Chester DiseaseLangerhans Cell HistiocytosisHistiocytic Disorders
Interventions
RADIATION

F-choline PET Scan

DEVICE

FDG-PET

PROCEDURE

biopsy

Trial Locations (1)

10065

Memoral Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02608619 - Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement | Biotech Hunter | Biotech Hunter